Anaheim, CANCT07686263Now EnrollingIRB Ready

Schizophrenia Clinical Trial in Anaheim, CA

Access cutting-edge schizophrenia treatment through this phase 3 clinical trial at a research site in Anaheim. Study-provided care at no cost to qualified participants.

Sponsored by Karuna Therapeutics, Inc., a Bristol Myers Squibb company

Quick Self-Assessment

See if you qualify for this Anaheim location

Preparing your pre-screening questions…

Expert Care in Anaheim

Access schizophrenia specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related schizophrenia treatment provided free

Apply for This Anaheim Location

Check if you qualify for this schizophrenia clinical trial in Anaheim, CA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Anaheim

    Convenient for CA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Anaheim site if eligible
  4. 4Begin participation

About This Schizophrenia Study in Anaheim

The purpose of the study is to evaluate the relapse prevention of KarXT in the treatment of participants with Schizophrenia

Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company

Who Can Participate

Inclusion Criteria

Participant must have a primary diagnosis of schizophrenia for at least 1 year established by a comprehensive psychiatric evaluation based on the DSM-5-TR (American Psychiatric Association 2022) criteria and confirmed by MINI for Psychotic Disorder Studies version 7.0.2 at screening.
Participant must have experienced hospitalization for schizophrenia within 1 year from the screening date.
Participant must be experiencing residual schizophrenia symptoms and have a PANSS total score ≥70 to ≤ 110 at screening and Day -1.
Participant much have a PANSS Score of ≥ 4 (moderate or greater) on ≥ 2 of the following Positive Scale (P) items at screening and Day -1:
Item 1 (P1; delusions)
Item 2 (P2; conceptual disorganization)
Item 3 (P3; hallucinatory behavior)
Item 6 (P6; suspiciousness/persecution)
Participant must have a CGI-S score of ≥ 4 at screening and Day -1
Participant must have a BMI ≥ 18 and ≤ 40 kg/m2.

Exclusion Criteria

Participant must not have any primary DSM-5 disorder other than schizophrenia within 12 months before screening
Participants must not have a newly diagnosed or are experiencing their first treated episode of psychosis or schizophrenia.
Participant must not have a risk of suicidal behavior as determined by the Investigator's clinical assessment and/or Columbia-suicide Severity Rating Scale (C-SSRS).
Participant must not have had psychiatric hospitalization(s) for more than 30 days (cumulative) within the 6 months before screening.
Participant must not have a history of treatment resistance to schizophrenia medications
Participant must not have decrease in PANSS total score (floor adjusted) between screening and Day -1 of more than 20%.
Other protocol-defined Inclusion/Exclusion criteria apply.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Anaheim?

Yes, this clinical trial (NCT07686263) has an active research site in Anaheim, CA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Schizophrenia Treatment Options in Anaheim, CA

If you're searching for schizophrenia treatment options in Anaheim, CA, this clinical trial (NCT07686263) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Anaheim research site is actively enrolling participants for this phase 3 clinical trial. You'll receive care from experienced schizophrenia specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all schizophrenia clinical trials near you to find additional studies recruiting in your area.

More Schizophrenia Trials in Anaheim, CA

See all schizophrenia clinical trials recruiting in Anaheim — not just this study.

Browse Schizophrenia Trials in Anaheim →

Browse More Trials by Condition

Schizophrenia TrialsPulmonary Hypertension TrialsAll Conditions →

Ready to Join in Anaheim?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Anaheim, CA